Recombinant type XVII humanized collagen improves skin damage of mice with systemic lupus erythematosus
A study published in Scientific Reports indicates that recombinant type XVII humanized collagen (rhCOL17) can reduce skin damage and inflammation in mice with systemic lupus erythematosus. The findings suggest a potential new therapeutic pathway for treating SLE-related skin lesions.
Why it matters
This research provides a promising preclinical foundation for developing targeted treatments for the dermatological symptoms of autoimmune diseases.
Scientific Reports ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in